Unknown

Dataset Information

0

Vaccine effectiveness against infection with the Delta (B.1.617.2) variant, Norway, April to August 2021.


ABSTRACT: Some variants of SARS-CoV-2 are associated with increased transmissibility, increased disease severity or decreased vaccine effectiveness (VE). In this population-based cohort study (n = 4,204,859), the Delta variant was identified in 5,430 (0.13%) individuals, of whom 84 were admitted to hospital. VE against laboratory confirmed infection with the Delta variant was 22.4% among partly vaccinated (95% confidence interval (CI): 17.0-27.4) and 64.6% (95% CI: 60.6-68.2) among fully vaccinated individuals, compared with 54.5% (95% CI: 50.4-58.3) and 84.4% (95%CI: 81.8-86.5) against the Alpha variant.

SUBMITTER: Seppala E 

PROVIDER: S-EPMC8414959 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC8569927 | biostudies-literature
| S-EPMC9991321 | biostudies-literature
| S-EPMC8314739 | biostudies-literature
| S-EPMC10169571 | biostudies-literature
| S-EPMC8518304 | biostudies-literature
| S-EPMC9671009 | biostudies-literature
| S-EPMC8552532 | biostudies-literature
| S-EPMC8865066 | biostudies-literature
| S-EPMC8486585 | biostudies-literature
| S-EPMC9288262 | biostudies-literature